These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Icodextrin reduces insulin resistance in non-diabetic patients undergoing automated peritoneal dialysis: results of a randomized controlled trial (STARCH). de Moraes TP, Andreoli MC, Canziani ME, da Silva DR, Caramori JC, Ponce D, Cassi HV, de Andrade Bastos K, Rio DR, Pinto SW, Filho SR, de Campos LG, Olandoski M, Divino-Filho JC, Pecoits-Filho R. Nephrol Dial Transplant; 2015 Nov; 30(11):1905-11. PubMed ID: 26063787 [Abstract] [Full Text] [Related]
25. Icodextrin Simplifies PD Therapy by Equalizing UF and Sodium Removal Among Patient Transport Types During Long Dwells: A Modeling Study. Akonur A, Sloand J, Davis I, Leypoldt J. Perit Dial Int; 2016 Nov; 36(1):79-84. PubMed ID: 25185017 [Abstract] [Full Text] [Related]
26. The effect of icodextrin and glucose-containing solutions on insulin resistance in CAPD patients. Gürsu EM, Ozdemir A, Yalinbas B, Gürsu RU, Canbakan M, Güven B, Atasoyu EM, Keskin AT, Elçi A, Baru Y. Clin Nephrol; 2006 Oct; 66(4):263-8. PubMed ID: 17063993 [Abstract] [Full Text] [Related]
27. Icodextrin effluent leads to a greater proliferation than glucose effluent of human mesothelial cells studied ex vivo. Bajo MA, Selgas R, Castro MA, del Peso G, Diaz C, Sánchez-Tomero JA, Fernandez de Castro M, Alvarez V, Corbí A. Perit Dial Int; 2000 Oct; 20(6):742-7. PubMed ID: 11216569 [Abstract] [Full Text] [Related]
29. A randomized clinical trial to evaluate the effects of icodextrin on left ventricular mass index in peritoneal dialysis. Cordeiro L, Ishikawa WY, Andreoli MCC, Canziani MEF, Araujo LKRP, Pereira BJ, Abensur H, Moysés RMA, Elias RM. Sci Rep; 2022 Sep 22; 12(1):15776. PubMed ID: 36138087 [Abstract] [Full Text] [Related]
32. Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients. Amici G, Orrasch M, Da Rin G, Bocci C. Adv Perit Dial; 2001 Sep 22; 17():80-3. PubMed ID: 11510303 [Abstract] [Full Text] [Related]
33. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution. Moriishi M, Kawanishi H, Watanabe H, Tsuchiya S. Adv Perit Dial; 2004 Sep 22; 20():166-9. PubMed ID: 15384820 [Abstract] [Full Text] [Related]
34. The kinetics of water transperitoneal transport during long-term peritoneal dialysis performed using icodextrin dialysis fluid. Olszowska A, Zelichowski G, Waniewski J, Stachowska-Pietka J, Weryński A, Wańkowicz Z. Pol Arch Med Wewn; 2009 May 22; 119(5):305-10. PubMed ID: 19579812 [Abstract] [Full Text] [Related]
35. A meta-analysis of icodextrin versus glucose containing peritoneal dialysis in metabolic management of peritoneal dialysis patients. He Q, Zhang W, Chen J. Ren Fail; 2011 May 22; 33(10):943-8. PubMed ID: 21929279 [Abstract] [Full Text] [Related]
37. Low-Polydispersity Glucose Polymers as Osmotic Agents for Peritoneal Dialysis. Leypoldt JK, Hoff CM, Akonur A, Holmes CJ. Perit Dial Int; 2015 May 22; 35(4):428-35. PubMed ID: 24584616 [Abstract] [Full Text] [Related]
38. Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials. Qi H, Xu C, Yan H, Ma J. Perit Dial Int; 2011 May 22; 31(2):179-88. PubMed ID: 21119069 [Abstract] [Full Text] [Related]